Weekly irinotecan in patients with metastatic colorectal cancer failing 5-fluorouracil-based chemotherapy: Efficacy and prognostic factors

Karaoglu, AZİZ; Yalcin, S; Tekuzman, G; Kars, A; Celik, I; Guler, N; Ozisik, Y; Turker, A; Barista, I; Gullu, I

doi:10.1177/030089160308900207

Weekly irinotecan in patients with metastatic colorectal cancer failing 5-fluorouracil-based chemotherapy: Efficacy and prognostic factors

Karaoglu A., Yalcin S., Tekuzman G., Kars A., Celik I., Guler N., ...Daha Fazla

TUMORI, cilt.89, sa.2, ss.141-145, 2003 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 89 Sayı: 2
Basım Tarihi: 2003
Doi Numarası: 10.1177/030089160308900207
Dergi Adı: TUMORI
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.141-145
Anahtar Kelimeler: colorectal cancer, irinotecan, recurrent
Dokuz Eylül Üniversitesi Adresli: Hayır

Özet

Aims and background: We evaluated the efficacy and tolerability of weekly irinotecan as a second-line treatment in patients with colorectal cancer failing 5-fluorouracil-based chemotherapy and searched for predictive and prognostic factors.